Floor E. Lubberman

Ede, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Vitamin B6 status and chronic chemotherapy-induced peripheral neuropathy: a prospective cohort study among patients with non-metastatic colorectal cancer receiving oxaliplatin-based chemotherapy.

Vitamin B6 status and chronic chemotherapy-induced peripheral neuropathy: a prospective cohort study among patients with non-metastatic colorectal cancer receiving oxaliplatin-based chemotherapy.

Journal: BMJ oncology

Published: May 03, 2024

Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study.

Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study.

Journal: British journal of cancer

Published: April 15, 2024

Folate, folic acid, and chemotherapy-induced toxicities: A systematic literature review.

Folate, folic acid, and chemotherapy-induced toxicities: A systematic literature review.

Journal: Critical reviews in oncology/hematology

Published: April 21, 2023

The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure.

The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure.

Journal: International journal of cancer

Published: September 28, 2020

A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics.

A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics.

Journal: Cancer chemotherapy and pharmacology

Published: May 26, 2019

The effect of gastrectomy on regorafenib exposure and progression-free survival in patients with advanced gastrointestinal stromal tumours.

The effect of gastrectomy on regorafenib exposure and progression-free survival in patients with advanced gastrointestinal stromal tumours.

Journal: British journal of clinical pharmacology

Published: March 31, 2019

The Effect of Using Pazopanib With Food vs. Fasted on Pharmacokinetics, Patient Safety, and Preference (DIET Study).

The Effect of Using Pazopanib With Food vs. Fasted on Pharmacokinetics, Patient Safety, and Preference (DIET Study).

Journal: Clinical pharmacology and therapeutics

Published: February 15, 2019

Fasting conditions in clinical oncology trials and drug labelling - Authors' reply.

Fasting conditions in clinical oncology trials and drug labelling - Authors' reply.

Journal: The Lancet. Oncology

Published: July 20, 2017

Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal.

Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal.

Journal: Acta oncologica (Stockholm, Sweden)

Published: April 08, 2017

Does a glass of Coke boost the exposure to imatinib in gastrointestinal stromal tumour patients after gastrectomy?

Does a glass of Coke boost the exposure to imatinib in gastrointestinal stromal tumour patients after gastrectomy?

Journal: British journal of clinical pharmacology

Published: February 20, 2017

Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma.

Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma.

Journal: Biomedical chromatography : BMC

Published: February 01, 2017

Poorly specified fasting conditions in clinical research could lead to treatment failure.

Poorly specified fasting conditions in clinical research could lead to treatment failure.

Journal: The Lancet. Oncology

Published: November 21, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026